Recursion Pharmaceuticals, Inc. (RXRX) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "RXRX"
      ],
      "issuer_cik": "0001601830",
      "owner_cik": "0001856094",
      "accession_number": "0001601830-26-000120",
      "form_type": "4",
      "filing_date": "2026-10-07",
      "period_of_report": "2026-10-06",
      "issuer_name": "RECURSION PHARMACEUTICALS, INC.",
      "issuer_trading_symbol": "RXRX",
      "owner_name": "Borgeson Blake",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Class A Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 50000,
      "transaction_price_per_share": 4.84,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 6108287,
      "transaction_value": 242000,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025."
        },
        {
          "id": "F2",
          "description": "This transaction was executed in multiple trades at prices ranging from $4.80 to $5.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."
        }
      ]
    },
    {
      "tickers": [
        "RXRX"
      ],
      "issuer_cik": "0001601830",
      "owner_cik": "0001274139",
      "accession_number": "0001601830-26-000119",
      "form_type": "4",
      "filing_date": "2026-10-07",
      "period_of_report": "2026-10-06",
      "issuer_name": "RECURSION PHARMACEUTICALS, INC.",
      "issuer_trading_symbol": "RXRX",
      "owner_name": "HERSHBERG ROBERT",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Class A Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 25000,
      "transaction_price_per_share": 5,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 162156,
      "transaction_value": 125000,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D"
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.